Elevation Oncology News, Elevation Oncology Quote, ELEV Quote

Elevation Oncology (NQ:ELEV) Delayed: 4.01 -0.13 (3.14%)

Prev. Close

$4.14

Open

$4.11

52 Wk High

$0.08

52 Wk Low

$0.01

Day High

$4.16

Day Low

$3.96

P/E

N/A

EPS

$0.00

Volume

318,846

Friends, Peers and Foes (?): CSPCY, NKTX, AMAM, ONCY AMGN (more...)

Apr 9, 2024 04:27 PM Form SC 13G Elevation Oncology, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Apr 8, 2024 04:30 PM Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Apr 5, 2024 04:15 PM Form 8-K Elevation Oncology, Inc. For: Apr 03
Mar 19, 2024 04:10 PM Form 4 Elevation Oncology, Inc. For: Mar 16 Filed by: Ferra Joseph J Jr
Mar 6, 2024 04:20 PM Elevation Oncology (ELEV) PT Raised to $8 at Wedbush
Mar 6, 2024 08:14 AM Form S-8 Elevation Oncology, Inc.
Mar 6, 2024 07:46 AM Form 8-K Elevation Oncology, Inc. For: Mar 06
Mar 6, 2024 07:30 AM Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
Mar 6, 2024 07:01 AM Form 10-K Elevation Oncology, Inc. For: Dec 31
Mar 5, 2024 04:50 PM Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

Entities mentioned with ELEV